Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Cardiovasc. Med., 26 November 2025

Sec. Lipids in Cardiovascular Disease

Volume 12 - 2025 | https://doi.org/10.3389/fcvm.2025.1744975

Correction: lipid and immunophenotypic profiles in hemodialysis patients with citrate vs. acetate dialysates

This article is a correction to:

  1. Lipid and immunophenotypic profiles in hemodialysis patients with citrate vs. acetate dialysates

    1. Read original article
Diana Rodríguez-Espinosa,Diana Rodríguez-Espinosa1,2Elena Cuadrado-PaynElena Cuadrado-Payán2Laura MorantesLaura Morantes2Miquel GomezMiquel Gomez2Francisco Maduell,Francisco Maduell1,2Jos Jesús Broseta, José Jesús Broseta1,2*
  • 1Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain
  • 2Department of Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, Barcelona, Spain

A Correction on

Lipid and immunophenotypic profiles in hemodialysis patients with citrate vs. acetate dialysates

By Rodríguez-Espinosa D, Cuadrado-Payán E, Morantes L, Gomez M, Maduell F and Broseta JJ. Front. Cardiovasc. Med. (2025). 12:1497353. doi: 10.3389/fcvm.2025.1497353

Affiliation "Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain" was omitted for the authors Diana Rodríguez-Espinosa, Francisco Maduell and José Jesús Broseta. This affiliation has now been added for the authors Diana Rodríguez-Espinosa, Francisco Maduell and José Jesús Broseta.

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: lipids, dyslipidemia, acetate, acetate-free, citrate, hemodialysis, dialysate

Citation: Rodríguez-Espinosa D, Cuadrado-Payán E, Morantes L, Gomez M, Maduell F and Broseta JJ (2025) Correction: lipid and immunophenotypic profiles in hemodialysis patients with citrate vs. acetate dialysates. Front. Cardiovasc. Med. 12:1744975. doi: 10.3389/fcvm.2025.1744975

Received: 12 November 2025; Accepted: 14 November 2025;
Published: 26 November 2025.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright: © 2025 Rodríguez-Espinosa, Cuadrado-Payán, Morantes, Gomez, Maduell and Broseta. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: José Jesús Broseta, ampicm9zZXRhQGNsaW5pYy5jYXQ=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.